Tivic Health appoints permanent CFO; CSO Gurfein departs; stockholders OK 425K share equity plan increase

Valion Bio, Inc.

Lisa Wolf appointed permanent CFO effective July 7, 2025; base salary $240,000 plus bonus up to 35% of base.
CSO Blake Gurfein stepped down July 4, 2025, to pursue other opportunities; will consult for at least 6 months at $20,000/month.
Gurfein receives lump sum severance of $45,938 upon signing release; no disagreement with company.
Stockholders approved amendment to 2021 Equity Plan to increase authorized shares by 425,000 (131,428 votes for).
Stockholders approved share issuances under Statera license, April 2025 SPA, and Mast Hill equity line.

item 5.02item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.